A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
Applications include detailed scientific rationale and supporting clinical evidence
Expands bioprocessing footprint across Asia
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose
The new site enables end-to-end production of viral vector gene therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
